Quantcast

Latest Daunorubicin Stories

2008-07-29 12:01:25

Celator Pharmaceuticals, which develops novel products based on proven combinations of chemotherapeutic drugs, has raised in excess of $22.5 million in a series C private equity financing.

2008-07-28 18:00:42

PRINCETON, N.J., July 28 /PRNewswire-FirstCall/ -- Celator Pharmaceuticals, a privately held pharmaceutical company developing novel products based on proven combinations of chemotherapeutic drugs, today announced that it raised in excess of $22.5 million in a Series C private equity financing.


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.